NCT07200921View on ClinicalTrials.gov

A Multicenter, Randomized, Double-blind, Placebo-controlled Trial on the Treatment of Hypertensive Intracerebral Hemorrhage With Naoxuekang Dropping Pills

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

1,950

Participants

Timeline

Start Date

October 10, 2025

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions
Hypertensive Intracerebral HemorrhageCerebral Small Vessel Diseases
Interventions
DRUG

Naoxuekang Dropping Pills

A traditional Chinese medicine. Each pill weighs 35mg. Dosage: 20 pills, three times daily, orally for 90 days.

DRUG

Naoxuekang Matching Placebo

A placebo pill matched to Naoxuekang Dropping Pills in appearance, taste , size, and packaging. Dosage: 20 pills, three times daily, orally for 90 days.

Trial Locations (1)

100070

Beijing Tiantan Hospital, Capital Medical University, Beijing

All Listed Sponsors
collaborator

The Affiliated Hospital of Qingdao University

OTHER

collaborator

Beijing Kangerfu Pharmaceutical Company Limited

UNKNOWN

lead

Beijing Tiantan Hospital

OTHER